ReviewSeminars in thrombosis and hemostasis2020
Thrombosis and Hemostasis Issues in Cancer Patients with COVID-19.
Review in Seminars in thrombosis and hemostasis, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 25 citations in OpenAlex.
- Elevated amputation rates in COVID-19 survivors: Insights from a large-scale Japanese cohort study.Journal of diabetes investigation · 2025Article
- Article
- Venous thromboembolism prophylaxis practices in hematology/oncology patients admitted to neurological intensive care units.Frontiers in cardiovascular medicine · 2025Article
- Validation of the CoVID-TE model as a tool to predict thrombosis, bleeding, and mortality in the oncology patient with Sars-Cov-2 infection: a study by the SEOM cancer and thrombosis group.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2024Article
- Cancer, more than a "COVID-19 co-morbidity".Frontiers in oncology · 2023Review
- Tissue factor in cancer-associated thromboembolism: possible mechanisms and clinical applications.British journal of cancer · 2022Review
- Approach to Thromboprophylaxis for Prevention of Venous Thromboembolism in COVID-19: Global Updates and Clinical Insights from India.Clinics and practice · 2022Review
- Venous thromboembolism risk, prophylaxis and management in cancer patients with COVID-19: An unmet medical need.Thrombosis update · 2022Review
- Learning through a Pandemic: The Current State of Knowledge on COVID-19 and Cancer.Cancer discovery · 2022Review
- Elevated risk of thrombotic manifestations of SARS-CoV-2 infection in cancer patients: A literature review.EXCLI journal · 2022Review
- ANMCO POSITION PAPER: cardio-oncology in the COVID era (CO and CO).European heart journal supplements : journal of the European Society of Cardiology · 2021Article
- Nonbacterial thrombotic endocarditis in a patient with gastric cancer and SARS-CoV-2 infection.Clinical journal of gastroenterology · 2021Article
- Current status of treatment of cancer-associated venous thromboembolism.Thrombosis journal · 2021Review
- Should COVID-19 be branded to viral thrombotic fever?Memorias do Instituto Oswaldo Cruz · 2021Article
- Cancer patients and COVID-19: Mortality, serious complications, biomarkers, and ways forward.Cancer treatment and research communications · 2021Review
- Factors associated with development of an acute ischemic event during hospitalization for COVID-19 in cancer and non-cancer patients.Annals of Saudi medicineArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.